Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 2 | 2019 | 141 | 0.620 |
Why?
|
| Polychaeta | 2 | 2016 | 3 | 0.550 |
Why?
|
| Cell Separation | 1 | 2017 | 55 | 0.530 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 13 | 0.530 |
Why?
|
| Germ Cells | 2 | 2013 | 15 | 0.500 |
Why?
|
| Flow Cytometry | 1 | 2017 | 291 | 0.490 |
Why?
|
| Arginine | 2 | 2013 | 42 | 0.490 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 44 | 0.490 |
Why?
|
| Drosophila melanogaster | 2 | 2013 | 62 | 0.480 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 78 | 0.470 |
Why?
|
| Body Patterning | 1 | 2014 | 7 | 0.420 |
Why?
|
| Wnt Proteins | 1 | 2014 | 34 | 0.410 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 66 | 0.410 |
Why?
|
| Aspartic Acid | 1 | 2013 | 52 | 0.410 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 127 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 453 | 0.200 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 38 | 0.200 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 148 | 0.180 |
Why?
|
| Antibody Formation | 2 | 2013 | 77 | 0.180 |
Why?
|
| Animals | 8 | 2019 | 10583 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2013 | 82 | 0.180 |
Why?
|
| Cell Movement | 2 | 2013 | 373 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 285 | 0.160 |
Why?
|
| Zebrafish | 2 | 2019 | 96 | 0.160 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 54 | 0.150 |
Why?
|
| Side-Population Cells | 1 | 2019 | 1 | 0.150 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 42 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 58 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2019 | 419 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 120 | 0.140 |
Why?
|
| Benzimidazoles | 1 | 2017 | 32 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 410 | 0.120 |
Why?
|
| Transcriptome | 1 | 2016 | 214 | 0.110 |
Why?
|
| Larva | 1 | 2014 | 28 | 0.110 |
Why?
|
| Consensus Sequence | 1 | 2013 | 17 | 0.100 |
Why?
|
| Antibody Diversity | 1 | 2013 | 5 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 66 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 8 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 85 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 41 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 284 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2013 | 452 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1494 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2014 | 1455 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 864 | 0.080 |
Why?
|
| Mice | 3 | 2013 | 4735 | 0.080 |
Why?
|
| Chromatin | 1 | 2023 | 76 | 0.050 |
Why?
|
| DNA Damage | 1 | 2023 | 151 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2013 | 51 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 375 | 0.050 |
Why?
|
| Spleen | 2 | 2013 | 113 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 314 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2016 | 14 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 21 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 39 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2016 | 22 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 25 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 128 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 126 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 78 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 156 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 489 | 0.030 |
Why?
|
| Phenylacetates | 1 | 2013 | 4 | 0.030 |
Why?
|
| Housing, Animal | 1 | 2013 | 2 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2013 | 6 | 0.030 |
Why?
|
| Haptens | 1 | 2013 | 9 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 2013 | 9 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 13 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 20 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2013 | 10 | 0.030 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2013 | 16 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2013 | 29 | 0.030 |
Why?
|
| Germinal Center | 1 | 2013 | 24 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2013 | 37 | 0.020 |
Why?
|
| Immunization | 1 | 2013 | 121 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 267 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 103 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 272 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 24 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 88 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 37 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 862 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 134 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 200 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 278 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 328 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 509 | 0.020 |
Why?
|
| Male | 1 | 2016 | 13772 | 0.010 |
Why?
|
| Female | 1 | 2016 | 15472 | 0.010 |
Why?
|
| Humans | 1 | 2019 | 28585 | 0.010 |
Why?
|